JavaScript is not enabled!...Please enable javascript in your browser

جافا سكريبت غير ممكن! ... الرجاء تفعيل الجافا سكريبت في متصفحك.

random
NEW
Home

Chronic myelogenous leucaemia (CML) :Causes, Types, Symptoms, Diagnosis ,Treatment , Risk factors , Complications , Prevention

What is Chronic myelogenous leukemia (CML)?

Chronic myelogenous leukemia (CML) is an uncommon form of cancer of the bone marrow — the spongy tissue within bones wherever blood cells square measure created. CML causes an associated degree of inflated range of white blood cells within the blood.

The term "chronic" in chronic myelogenous leukemia indicates that this cancer tends to progress more slowly than acute varieties of leukemia. The term "myelogenous" (my-uh-LOJ-uh-nus) in chronic myelogenous leukemia refers to the kind of cells laid low with this cancer.

Chronic myelogenous leukemia may also be known as chronic myelocytic leukemia and chronic leukemia. It usually affects older adults and barely happens in kids, although it will occur at any age.

Advances in treatment have contributed to a greatly improved prognosis for folks with chronic myelogenous leukemia. The majority can accomplish remission and live for several years after designation. 


Chronic myelogenous leukemia (CML)

Medical term

 Chronic myelogenous sickness} could be a disease within which the bone marrow makes too many white blood cells.

Leukemia might have an effect on red blood cells, white blood cells, and platelets.

Signs and symptoms of chronic myelogenous malignant neoplastic disease embrace weight loss and fatigue.

Most people with CML have a point mutation (change) known as the Philadelphia body.

Tests that examine the blood and bone marrow area unit accustomed diagnose chronic myelogenous malignant neoplastic disease.

Certain factors have an effect on prognosis (chance of recovery) and treatment choices.

Chronic myelogenous sickness} could be a disease within which the bone marrow makes too many white blood cells.

Chronic myelogenous sickness} (also known as CML or chronic white blood corpuscle leukemia) could be a slowly progressing blood and bone marrow disease that typically happens throughout or at time of life, and infrequently happens in youngsters.

  • ENLARGEAnatomy of the bone; drawing shows spongy bone, red marrow, and bone marrow. A cross section of the bone shows compact bone and blood vessels within the bone marrow. additionally shown area unit red blood cells, white blood cells, platelets, and a blood vegetative cell.

  • Anatomy of the bone. The bone is created from compact bone, spongy bone, and bone marrow. Compact bone makes up the outer layer of the bone. Spongy bone is found largely at the ends of bones and contains bone marrow. Bone marrow is found within the center of most bones and has several blood vessels. There are 2 varieties of bone marrow: red and yellow. bone marrow contains blood stem cells that may become red blood cells, white blood cells, or platelets. bone marrow is created largely of fat.

  • Leukemia might have an effect on red blood cells, white blood cells, and platelets.

  • Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. A blood vegetative cell might become a myeloid vegetative cell or a liquid body substance vegetative cell. A liquid body substance vegetative cell becomes a white corpuscle.

  • A myeloid vegetative cell becomes one in every of 3 varieties of mature blood cells:

  • Red blood cells that carry O and alternative substances to any or all tissues of the body.

  • Platelets that type blood clots to prevent hemorrhage.

  • Granulocytes (white blood cells) that fight infection and illness.

  • ENLARGEBlood cell development; drawing shows the steps a blood vegetative cell goes through to become a red corpuscle, platelet, or white corpuscle. A myeloid vegetative cell becomes a red corpuscle, a platelet, or a white corpuscle, that then becomes a white cell (the varieties of granulocytes area unit eosinophils, basophils, and neutrophils). A liquid body substance vegetative cell becomes a lymphocyte so becomes a B-lymphocyte, T-lymphocyte, or natural CD8 cell.

  • Blood cell development. A blood vegetative cell goes through many steps to become a red corpuscle, platelet, or white corpuscle.

  • In CML, too, several blood stem cells become a sort of white corpuscle known as granulocytes. These granulocytes are abnormal and don't become healthy white blood cells. they're additionally known as malignant neoplastic disease cells. The malignant neoplastic disease cells will build up within the blood and bone marrow therefore there's less area for healthy white blood cells, red blood cells, and platelets. Once this happens, infection, anemia, or simple hemorrhage might occur. 

  1. What is Blood?
  2. What Is a Circulatory System?

Types of leukemia

There are four main types of leukemia, which are determined by the type of white blood cell that is affected and how quickly the leukemia develops. The four main types of leukemia are:  acute lymphocytic leukemia (ALL), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and chronic myeloid leukemia (CML).

 

The primary kinds of leukemia are:

  • Acute lymphocytic leukemia (ALL). This is the maximum not unusual type of leukemia in young kids. ALL can also arise in adults.

  • Acute myelogenous leukemia (AML). AML is a not unusual form of leukemia. It occurs in children and adults. AML is the most common type of acute leukemia in adults.

  • Hairy cell leukemia (HCL). Hairy cell leukemia (HCL) is a rare, chronic leukemia characterized by the presence of atypical circulating B lymphocytes, called hairy cells, in the peripheral blood.

  • Chronic myelogenous leukemia (CML). This type of leukemia in particular impacts adults. An individual with CML may have few or no signs for months or years earlier than getting into a segment wherein the leukemia cells develop greater quickly.

  • Other kinds. Other, rarer kinds of leukemia exist, including hairy cell leukemia, myelodysplastic syndromes and myeloproliferative problems.

Symptoms Chronic myelogenous leukemia (CML)

Chronic myelogenous leukemia (CML) is a bone marrow disorder that can occur at any age. It is a cancer of the white blood cells, characterized by an uncontrolled overproduction of immature white blood cells known as myeloblasts. Symptoms can include fatigue, fever, weight loss, night sweats and full body itching. In some cases, symptoms of anemia such as pale skin, weakness, dizziness, and a fast heart rate may develop due to low red blood cell count.

Chronic myelogenous leukemia usually does not cause signs and symptoms. it'd be detected throughout a biopsy.

  • Fever

  • Weight loss without trying

  • Loss of appetite

  • Pain or fullness below the ribs on the left side

  • Excessive sweating during sleep (night sweats)

  • Bone pain

  • Easy bleeding

  • Feeling full after eating a small amount of food

  • Feeling run-down or tired

When to see a doctor

  If you develop symptoms, like bone pain, fatigue, night sweats or alternative symptoms of CML, schedule a consultation together with your health care supplier directly. If you’re presently undergoing treatment for CML, decide your supplier anytime you develop new facet effects. they will notice ways in which to ease your symptoms and improve your quality of life.

 

Make a rendezvous together with your doctor if you've got any persistent signs or symptoms that worry you .

Causes Chronic myelogenous leukemia (CML)

Chronic myelogenous cancer of the blood happens once one thing goes awry within the genes of your bone marrow cells. It is not clear what ab initio trigger off this method, however doctors have discovered however it progresses into chronic myelogenous cancer of the blood.

An abnormal chromosome develops

Human cells typically contain twenty 3 pairs of chromosomes. These chromosomes hold the polymer that contains the directions (genes) that manage the cells in your body. In those of us with chronic myelogenous cancer, the chromosomes at intervals the blood cells swap sections with each other. a section of body 9 switches places with a section of body twenty 2, creating Associate in Nursing extra-short body twenty 2 ANd Associate in Nursing extra-long body 9.

The abnormal chromosome creates a new gene

The extra-short body twenty 2 is termed the metropolis body, named for the city where it completely was discovered. The metropolis body is a gift among the blood cells of ninety you look after people with chronic myelogenous cancer.

The new gene allows too many diseased blood cells

Your blood cells originate within the bone marrow, a spongy material within your bones. Once your bone marrow functions unremarkably, it produces immature cells (blood stem cells) in an exceedingly controlled manner. These cells then mature and specialize into the varied sorts of blood cells that flow into your body — red cells, white cells and platelets.

 

In chronic myelogenous leukemia, this method does not work properly. The amino alkanoic acid enzyme caused by the BCR-ABL factor permits too many white blood cells to grow. Most or all of those cells contain the abnormal City of Brotherly Love body. The pathologic white blood cells do not grow and die like traditional cells. The pathologic white blood cells build up in immense numbers, state of affairs out healthy blood cells and damaging the bone marrow.

Risk factors Chronic myelogenous leukemia (CML)

If you’ve been diagnosed with CML, you’ll probably be prescribed medications which will keep your cancer at bay. you ought to take these medications specifically as directed by your health care supplier. Most of the people with CML attend frequent, routine appointments to examine how well their treatment is functioning. 

Is CML fatal?

In the past, CML was thought-about a deadly unwellness. Today, trendy treatment choices have considerably improved the outlook of individuals with CML. Before the appearance of targeted drug medical aid, the five-year survival rate for folks with CML was solely twenty second. Today, the general five-year survival rate is ninetieth. (This means ninetieth of individuals diagnosed with CML square measure are still alive 5 years later.) This applied math improvement is essentially because of the TKIs employed in targeted drug medical aid.

 

Keep in mind that survival rates square measure estimates supported the outcomes of individuals with CML within the past. These numbers cannot tell you how long you’ll live or what to expect in your specific case. to find out additional survival rates, speak together with your health care supplier.

Factors that increase the risk of chronic myelogenous leukemia:

  • Older age

  • Being male

  • Radiation exposure, such as radiation therapy for certain types of cancer

Family history is not a risk factor

The mutation that leads to chronic myelogenous leukemia isn't passed from parents to children. This mutation is believed to be acquired, meaning it develops after birth.

Diagnosis Chronic myelogenous leukemia (CML)

CML is most typically found throughout a routine blood count. If your attention supplier suspects that you simply might have CML, they'll order additional tests to verify your designation. These tests might include:

A physical examination. Your attention supplier can check your important signs and gently press around your abdomen and humor nodes to ascertain if something feels abnormal.

Bone marrow diagnostic test. Bone marrow samples are taken — usually from your hip bone — and sent to a pathology work for analysis.

FISH (fluorescence in place hybridization) analysis. This check uses visible light to observe and find genetic material in your cells.

PCR (polymerase chain reaction) check. PCR will build voluminous copies of a desoxyribonucleic acid section. This is often helpful once additional assessments get to be performed.

Tests and procedures used to diagnose chronic myelogenous leukemia include:

  • Bone marrow tests. Bone marrow biopsy and bone marrow aspiration are used to collect bone marrow samples for laboratory testing. These tests involve collecting bone marrow from your hip bone.

  • Tests to look for the Philadelphia chromosome. Specialized tests, such as fluorescence in situ hybridization (FISH) analysis and the polymerase chain reaction (PCR) test, analyze blood or bone marrow samples for the presence of the Philadelphia chromosome or the BCR-ABL gene.

Phases of chronic myelogenous leukemia

The phase of chronic myelogenous leukemia refers to the aggressiveness of the disease. Your doctor determines the phase by measuring the proportion of diseased cells to healthy cells in your blood or bone marrow. A higher proportion of diseased cells means chronic myelogenous leukemia is at a more advanced stage.

  • Physical exam. Your doctor will examine you and check such vital signs as pulse and blood pressure. He or she will also feel your lymph nodes, spleen and abdomen to determine whether they are enlarged.

  • Blood tests. A complete blood count may reveal abnormalities in your blood cells, such as a very high number of white blood cells. Blood chemistry tests to measure organ function may also reveal abnormalities that can help your doctor make a diagnosis.

Phases of chronic myelogenous leukemia include:

  • Chronic. The chronic phase is the earliest phase and generally has the best response to treatment.

  • Accelerated. The accelerated phase is a transitional phase when the disease becomes more aggressive.

  • Blast. Blast phase is a severe, aggressive phase that becomes life-threatening.

Chronic myelogenous leukemia blood test

Many times chronic myelogenous leukemia (CML) is diagnosed with a blood test Your doctor may order tests to check the function of your bone marrow including: Complete Blood Count (CBC): A CBC determines the number of blood cells in your body and may indicate CML The CBC also checks for anemia which can be caused by low levels of red blood cells or low levels of hemoglobin in red blood cells Anemia can occur when you have CML A CBC determines the number of blood cells in your body and may indicate CML The CBC also checks for anemia which can be caused by low levels of red blood cells or low levels of hemoglobin in red blood cells.

Chronic myelogenous leukemia life expectancy

Chronic myelogenous leukemia or CML is a cancer of the blood and bone marrow It affects more than 15,000 people in the United States each year In most cases survival rates are good for people with CML The type of treatment you choose depends on your specific case and how far the disease has progressed.

Chronic myelogenous leukemia treatment

Myeloid leukemia is a cancer of the bone marrow It begins in the cells that normally develop into white blood cells and platelets When these abnormal bone marrow cells divide they produce more cancerous cells and less healthy red blood cells white blood cells and platelets A person with myeloid leukemia will have an abnormal number of immature white blood cells in the bloodstream This can lead to infections and an increased risk of infection.

Treatment Chronic myelogenous leucaemia (CML)

The goal of chronic myelogenous leukemia treatment is to eliminate the blood cells that contain the abnormal BCR-ABL factor that causes the overabundance of pathologic blood cells. For many individuals, treatment begins with targeted medication that will facilitate a semi-permanent remission of the malady.

 

Targeted drug medical aid is sometimes the primary line of treatment against chronic myelogenous leukemia. This approach targets the cells that contain the abnormal BCR-ABL factor. medication employed in this kind of medical aid area unit known as amino alkanoic acid enzyme inhibitors (TKIs) and that they embody Dasatinib (Sprycel), Imatinib (Gleevec), Ponatinib (Iclusig), Bosutinib (Bosulif) and Nilotinib (Tasigna). The goal of TKIs is to attain a semi permanent remission of the cancer.

Some individuals with chronic myelogenous leukemia might have alternative treatments, such as:

Chemotherapy. Throughout this treatment, anti-cancer medication area units are taken in pill type or given through a vein. Typically therapy is combined with targeted drug medical aid. it's going to even be suggested if TKIs shut down further.

Interferon medical aid. Interferons area unit substances created naturally by your system. Antiviral drug medical aid uses an artificial drug (interferon alpha) that mimics the natural interferons found in your body. This helps cut back the expansion of leukemia cells. Before amino alkanoic acid enzyme inhibitors, antiviral drug medical aid was the simplest treatment accessible for CML.

Stem cell transplant. As a result of TKIs area unit the foremost effective treatment against CML, somatic cell transplants area unit performed way less typically recently. However, your supplier could advocate a somatic cell transplant if you’re not responding well to TKIs.

Radiation medical aid. This approach isn’t sometimes suggested for individuals with CML, however it's going to be useful in bound things. As an example, people who endure a somatic cell transplant could receive radiotherapy beforehand to arrange their body for the procedure.

Though surgery isn’t an associated choice for directly treating CML, a cutting out could also be necessary if the leukemia spreads to the spleen. Once leukemia affects the spleen, it will become enlarged and it puts excess pressure on nearby organs. It’s vital to notice, however, that surgery has no role in treating chronic myelogenous leukemia.

  1. Bone marrow transplant (BMT)
  2. Circulatory Rehabilitation
  3. Psychological rehabilitation for cancer

Targeted drug therapy

Targeted drugs are designed to attack cancer by focusing on a specific aspect of cancer cells that allows them to grow and multiply. In chronic myelogenous leukemia, the target of these drugs is the protein produced by the BCR-ABL gene — tyrosine kinase.

Targeted drugs that block the action of tyrosine kinase include:

  • Imatinib (Gleevec)

  • Dasatinib (Sprycel)

  • Nilotinib (Tasigna)

  • Bosutinib (Bosulif)

  • Ponatinib (Iclusig)

Targeted drugs square measure the initial treatment for people diagnosed with chronic myelogenous malignant growth illness. side effects of these targeted drugs embrace swelling or lump of the skin, nausea, muscle cramps, fatigue, diarrhea and skin rashes.

 

Blood tests to find the presence of the BCR-ABL factor square measure accustomed monitor the effectiveness of targeted drug treatment. If the illness doesn't respond or becomes proof against targeted treatment, doctors would possibly ponder completely different targeted drugs, like omacetaxine (Synribo), or completely different treatments.

 

Doctors haven't determined a secure purpose so that people with chronic myelogenous malignant growth illness can stop taking targeted drugs. For this reason, the final public still takes targeted drugs even once blood tests show remission of the illness. In positive things, you and your doctor might ponder stopping treatment with targeted drugs once considering the benefits and risks.

Bone marrow transplant

A bone marrow transplant, conjointly referred to as a somatic cell transplant, offers the sole likelihood for a definitive cure for chronic myelogenous leukemia. However, it has always been reserved for those who haven't been helped by alternative treatments as a result of bone marrow transplants having risks and carrying a high rate of significant complications.

 

During a bone marrow transplant, high doses of therapy medicine square measure accustomed to killing the blood-forming cells in your bone marrow. Then blood stem cells from a donor square measure infused into your blood. The new cells type new, healthy blood cells to interchange the pathologic cells.

Chemotherapy

Chemotherapy is a drug treatment that kills fast-growing cells in the body, including leukemia cells. Chemotherapy drugs are sometimes combined with targeted drug therapy to treat aggressive chronic myelogenous leukemia. Side effects of chemotherapy drugs depend on what drugs you take.

Clinical trials

Clinical trials study the newest treatment for diseases or new ways of mistreating existing treatments. Enrolling during a trial for chronic myelogenous leukemia could offer you the prospect to undertake the newest treatment, however it cannot guarantee a cure. refer to your doctor regarding what clinical trials are obtainable to you. along you'll discuss the advantages and risks of a trial.

Lifestyle and home remedies

For many people, chronic myelogenous leukemia is a disease they will live with for years. Many will continue treatment with imatinib indefinitely. Some days, you may feel sick even if you don't look sick. And some days, you may just be sick of having cancer. Self-care measures to help you adjust and cope with a chronic illness include:

  • Talk to your doctor about your side effects. Powerful cancer medications can cause many side effects, but those side effects often can be managed with other medications or treatments. You don't necessarily have to touch them out.

  • Don't stop treatment on your own. If you develop unpleasant side effects, such as skin rashes or fatigue, don't simply quit your medication without consulting your health care professionals. Likewise, don't stop taking your medications if you feel better and think your disease may be gone. If you stop taking medication, your disease can quickly and unexpectedly return, even if you've been in remission.

  • Ask for help if you're having trouble coping. Having a chronic condition can be emotionally overwhelming. Tell your doctor about your feelings. Ask for a referral to a counselor or other specialist with whom you can talk.

Alternative medicine

No different medicines are found to treat chronic myelogenous malignant neoplastic disease. However, practice of medicine might assist you address fatigue, which is often caused by folks with chronic myelogenous malignant neoplastic disease.

 

You might experience fatigue as a signal of your malady, a facet result of treatment or as a part of the strain that comes with living with a chronic condition. Your doctor will treat fatigue by dominating the underlying causes, however medications alone are not enough.

You may find relief through alternative therapies, such as:

  • Exercise

  • Journal writing

  • Massage

  • Relaxation techniques

  • Yoga

Talk to your doctor about your options. Together you can devise a plan to help you cope with fatigue.

Coping and support

Chronic myelogenous leukemia often is a chronic disease and requires long-term treatments. To help you cope with your cancer journey, try to:

  • Learn enough about chronic myelogenous leukemia to make decisions about your care. The term "leukemia" can be confusing, because it refers to a group of cancers that affect the bone marrow and blood. Don't waste time gathering information that doesn't apply to your kind of leukemia.
    Ask your health care professionals to write down information about your specific disease. Then narrow your search and seek out only trusted, reputable sources, such as the Leukemia & Lymphoma Society.

  • Turn to family and friends for support. Stay connected to family and friends for support. It can be tough to talk about your diagnosis, and you'll likely get a range of reactions when you share the news. But talking about your diagnosis and passing along information about your cancer can help. So can the offers of practical help that often result.

  • Connect with other cancer survivors. Consider joining a support group, either in your community or on the internet. A support group of people with the same diagnosis can be a source of useful information, practical tips and encouragement.

Preparing for your appointment

Start by creating an arrangement together with your general practitioner if you've got any signs or symptoms that worry you. If blood tests or alternative tests and procedures recommend malignant neoplastic disease, your doctor could refer you to a specialist within the treatment of blood and bone marrow diseases and conditions (hematologist).

 

Because appointments may be temporary, and since there is usually plenty of ground to hide, it is a smart plan to be ready. Here's some info to assist you prepare, and what to expect from your doctor.

What you can do

  • Be aware of any pre-appointment restrictions. At the time you make the appointment, be sure to ask if there's anything you need to do in advance, such as restrict your diet.

  • Write down any symptoms you're experiencing, including any that may seem unrelated to the reason for which you scheduled the appointment.

  • Write down key personal information, including any major stresses or recent life changes.

  • Make a list of all medications, vitamins or supplements that you're taking.

  • Consider taking a family member or friend along. Sometimes it can be difficult to take in all the information provided during an appointment. Someone who accompanies you may remember something that you missed or forgot.

If you’ve been diagnosed with CML, gaining AN understanding of your scenario will assist you create abreast of selections relating to treatment. Here area unit some inquiries to contemplate asking your healthcare provider: 

  • Will I be able to work during my treatment?

  • How often will you perform blood tests to see how my treatment is working?

  • Would a stem cell transplant be helpful in my case?

  • How common is it for CML to come back after remission?

  • What phase of chronic myelogenous leukemia do I have?

  • What are my treatment options?

  • What will my treatment feel like?

  • Who can I talk to about managing my treatment costs?

  • Write down questions to ask your doctor.

Your time with your doctor is limited, so preparing a list of questions will help make the most of your time together. List questions from most important to least important in case time runs out. For chronic myelogenous leukemia, some basic questions to ask your doctor include:

  • Can you explain what my test results mean?

  • Do you recommend any other tests or procedures?

  • What is the phase of my CML?

  • What are my treatment options?

  • What side effects are likely with each treatment?

  • How will treatment affect my daily life?

  • Which treatment options do you think are best for me?

  • How likely is it that I'll achieve remission with the treatments you recommend?

  • How quickly must I make a decision on my treatment?

  • Should I get a second opinion from a CML specialist? What will that cost, and will my insurance cover it?

  • Are there brochures or other printed material that I can take with me? What websites do you recommend?

In addition to the questions that you've prepared to ask your doctor, don't hesitate to ask other questions that occur to you.

What to expect from your doctor

Your doctor is likely to ask you a number of questions. Being ready to answer them may allow time later to cover other points you want to address. Your doctor may ask:

  • When did you first begin experiencing symptoms?

  • Have your symptoms been continuous or occasional?

  • How severe are your symptoms?

  • What, if anything, seems to improve your symptoms?

  • What, if anything, appears to worsen your symptoms?

 

General summary           

(CML) Chronic myelogenous leukemia (CML) is a type of cancer in which the bone marrow makes abnormal white blood cells called monocytes CML is also known as chronic granulocytic leukemia and it's the most common form of acute leukemia People who have CML typically experience fatigue weakness weight loss and/or fever They may also develop an enlarged spleen or liver or they may bleed easily.

(CML) Chronic myelogenous leukemia (CML) is a form of cancer that originates in. blood-forming tissue especially the bone marrow CML accounts for about 20 percent of all adult leukemias and generally occurs in older adults Some people with CML have no symptoms while others experience fatigue anemia and frequent infections In most cases treatment to cure CML involves chemotherapy consisting of several drugs taken for about two years.


Chronic myelogenous leucaemia (CML) :Causes, Types, Symptoms, Diagnosis ,Treatment , Risk factors  , Complications , Prevention

usa-good- clinic

Comments
    No comments
    Post a Comment
      NameEmailMessage